BROADCASTS.com

Every week, The American Journal of Managed Care\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care stories included CMS reversing its decision to suspend the risk adjustment payment program; out-of-pocket costs and copayment accumulators put an HIV prevention drug out of reach for patients; research finds geography can determine posttreatment imaging for women with breast cancer.\n\nRead more about the stories in this podcast:\nWhat We're Reading: Resuming Risk Adjustment Program; New Endometriosis Drug; Lilly Denounces Drug Imports: https://www.ajmc.com/newsroom/what-were-reading-resuming-risk-adjustment-program-new-endometriosis-drug-lilly-denounces-drug-imports\nPrEP for HIV Prevention: Essential for Ending the Epidemic, but Out of Reach for Many: https://www.ajmc.com/focus-of-the-week/prep-for-hiv-prevention-essential-for-ending-the-epidemic-but-out-of-reach-for-many\nGeography Influences Type of Posttreatment Imaging Received After Early Breast Cancer: https://www.ajmc.com/newsroom/geography-influences-type-of-posttreatment-imaging-received-after-early-breast-cancer\nFDA Releases Biosimilar Action Plan: https://www.centerforbiosimilars.com/news/fda-releases-biosimilar-action-plan\nThe Center for Biosimilars\xae:\xa0https://www.centerforbiosimilars.com/